Rhythm Biosciences Ltd has released a press release.
Study 7 Confirms ColoSTAT Meets Primary Endpoint
Filed with ASX ·
6ix hasn’t read this filing yet.
Rhythm Biosciences Limited on 6ix
In the deck
Earlier from Rhythm Biosciences
- S&P DJI Announces March 2022 Quarterly Rebalance
- Rhythm Biosciences - Investor Webinar Presentation
- Appendix 4D and Half Yearly Report and Accounts
- Rhythm Maintains Ongoing ISO13485 Certification
- Placement of $6.5m to Global Institutional Funds Manager
Later from Rhythm Biosciences
- Rhythm Biosciences - Investor Presentation
- Rhythm Biosciences: RHY Presentation at PAC Partners Healthcare Conference
- Appendix 4C - quarterly
- Rhythm Closes Final Clinical Trial Site
- Completion of Final TGA Submission Step to Approve ColoSTAT
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences